Risk of depression in multiple sclerosis across disease-modifying therapies

BACKGROUND: Depression and use of antidepressants are more common among patients with multiple sclerosis (MS) compared to the general population, but the relation of psychiatric comorbidity to use of different disease-modifying therapies (DMTs) is less clear. OBJECTIVE: To determine whether risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Longinetti, Elisa, Frisell, Thomas, Englund, Simon, Reutfors, Johan, Fang, Fang, Piehl, Fredrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961249/
https://www.ncbi.nlm.nih.gov/pubmed/34264143
http://dx.doi.org/10.1177/13524585211031128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961249/
https://www.ncbi.nlm.nih.gov/pubmed/34264143
http://dx.doi.org/10.1177/13524585211031128

Ejemplares similares